On an average, the mass of SGC-7901 cells that formed tumors in the lenti-GPC5-AS1 transfected SGC-7901 treatment group was only 19.0 % of the total tumor weight in the control (Figure 2D), whereas the mass of BGC-823 cells that formed tumors in the lenti-GPC5-AS1 transfected BGC-823 treatment group was approximately 27.1 % of the total tumor weight in the control (Figure 2H). Here, GPC5 is linked to neoplasm.